Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP161317.RAQ-4SqALFyKrDetH9bUsjlH95YBELTrsh9_YbegbA-kI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP161317.RAQ-4SqALFyKrDetH9bUsjlH95YBELTrsh9_YbegbA-kI130_assertion type Assertion NP161317.RAQ-4SqALFyKrDetH9bUsjlH95YBELTrsh9_YbegbA-kI130_head.
- NP161317.RAQ-4SqALFyKrDetH9bUsjlH95YBELTrsh9_YbegbA-kI130_assertion description "[PCR-based assays showed that alcoholism was associated with polymorphisms of the dopamine D2 receptor (DRD2) TaqI B (P = .029) and the GABAA-beta2 subunit C1412T (P = .012) genes, but not with the glutamate receptor subunit gene NMDAR2B (366C/G), the serotonin transporter gene (5HTTL-PR), the dopamine transporter gene DAT1(SLC6A3), the dopamine D2 receptor gene DRD2 TaqI A, or the GABAA alpha1(A15G), alpha6(T1519C), and gamma2(G3145A) subunit genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP161317.RAQ-4SqALFyKrDetH9bUsjlH95YBELTrsh9_YbegbA-kI130_provenance.
- NP161317.RAQ-4SqALFyKrDetH9bUsjlH95YBELTrsh9_YbegbA-kI130_assertion evidence source_evidence_literature NP161317.RAQ-4SqALFyKrDetH9bUsjlH95YBELTrsh9_YbegbA-kI130_provenance.
- NP161317.RAQ-4SqALFyKrDetH9bUsjlH95YBELTrsh9_YbegbA-kI130_assertion SIO_000772 15542698 NP161317.RAQ-4SqALFyKrDetH9bUsjlH95YBELTrsh9_YbegbA-kI130_provenance.
- NP161317.RAQ-4SqALFyKrDetH9bUsjlH95YBELTrsh9_YbegbA-kI130_assertion wasDerivedFrom befree-20140225 NP161317.RAQ-4SqALFyKrDetH9bUsjlH95YBELTrsh9_YbegbA-kI130_provenance.
- NP161317.RAQ-4SqALFyKrDetH9bUsjlH95YBELTrsh9_YbegbA-kI130_assertion wasGeneratedBy ECO_0000203 NP161317.RAQ-4SqALFyKrDetH9bUsjlH95YBELTrsh9_YbegbA-kI130_provenance.